British National Formulary

British National Formulary
source
Title	British National Formulary
Discipline	Pharmacology
Country	United Kingdom
Firstdate	1949
Frequency	Biannual

British National Formulary is a pharmaceutical reference guide published for health professionals that provides recommendations on prescribing, dispensing, and administering medicines. The work is used across hospitals, primary care, and community pharmacies and interacts with professional bodies, regulatory agencies, and academic institutions. It connects prescribing practice with formularies, guidance, and standards developed by entities in the United Kingdom, the European Union, and international health organizations.

History and development

The origins trace to post‑war efforts to standardize therapeutics alongside institutions such as the National Health Service and collaborations involving the Royal College of Physicians, the British Medical Association, and the Royal Pharmaceutical Society. Early editions reflected influences from the Cochrane Collaboration movement in evidence synthesis and paralleled developments at the World Health Organization and the European Medicines Agency. Over decades the reference evolved through interactions with regulatory milestones like the Medicines Act 1968 and the creation of licensing frameworks associated with the Medicines and Healthcare products Regulatory Agency. The resource adapted during periods notable for pharmacological advances, including the introduction of antibiotics linked to discoveries by figures related to the Nobel Prize in Medicine and the rise of therapies implicated in debates at events such as the Thalidomide inquiry. Institutional changes at bodies like the British Pharmacopoeia Commission and collaborations with academic centres such as the London School of Hygiene & Tropical Medicine influenced successive revisions.

Organization and content

Content is arranged by therapeutic area and includes monographs, dosing guidance, contraindications, interactions, and monitoring recommendations. Sections align with classification systems influenced by the Anatomical Therapeutic Chemical Classification System and draw on formularies used by national services including the NHS England formularies, regional commissioners, and specialist advisory groups like the National Institute for Health and Care Excellence. Chapters reference clinical guidelines produced by organisations such as the Royal College of General Practitioners, the Royal College of Paediatrics and Child Health, and the Royal College of Obstetricians and Gynaecologists. Safety alerts and pharmacovigilance data reflect rapport with the Yellow Card Scheme and agencies like the European Commission Directorate responsible for public health. Cross‑references include vaccines overseen by the Joint Committee on Vaccination and Immunisation and therapeutics evaluated in portals maintained by the BioBank-affiliated research networks.

Editions and formats

The publication is issued in print, digital, and app formats and is updated regularly to reflect licensing changes made by the European Medicines Agency and national regulators. Special editions and local adaptations are produced by trusts, integrated care systems, and educational providers including university press partnerships with institutions such as University College London and the University of Oxford. Electronic formats integrate with clinical systems from suppliers like EMIS Health, Tunstall Healthcare, and Cerner Corporation while also informing procurement and formularies used by hospital trusts such as Guy's and St Thomas' NHS Foundation Trust and Barts Health NHS Trust. Historic print runs mirror publishing trends seen at houses like Wiley-Blackwell and corporate restructurings similar to those of Pearson PLC.

Editorial process and governance

An editorial committee comprising clinicians, pharmacists, and specialists from organisations including the Royal College of Anaesthetists and the Royal College of Psychiatrists oversees content. Governance interacts with statutory bodies such as the General Medical Council and the General Pharmaceutical Council to align professional standards. Expert advisory panels source evidence from randomized controlled trials published in journals like The Lancet, BMJ, and New England Journal of Medicine and consult systematic reviews from groups analogous to the Cochrane Collaboration. Conflict of interest policies reference frameworks used by the Committee on Publication Ethics and institutional guidance from funding bodies such as the National Institute for Health Research.

Clinical use and impact

Clinicians employ the book for prescribing decisions in specialties from cardiology to paediatrics, interacting with guidelines from the British Heart Foundation and treatment pathways shaped by NHS specialty commissioners. It influences antimicrobial stewardship programmes influenced by campaigns run with organisations like Public Health England and has been cited in audits by bodies such as the Care Quality Commission. Education for trainees uses the reference alongside curricula from the Joint Royal Colleges of Physicians Training Board and examination syllabuses of the Membership of the Royal Colleges of Physicians assessments. Health outcomes research connecting formulary use to prescribing quality appears in studies by universities including King's College London and Imperial College London.

Access, licensing, and distribution

Access is provided via institutional subscriptions negotiated with trusts, higher education institutions, and commercial partners similar to arrangements with vendors like Elsevier and Elsevier Health Sciences. Licensing models balance open use in public health initiatives such as vaccination campaigns coordinated with the Department of Health and Social Care against proprietary digital rights managed under contracts resembling those used by the National Health Service procurement frameworks. Distribution channels include hospital libraries, community pharmacy networks represented by organisations such as the Pharmaceutical Services Negotiating Committee and academic libraries affiliated with the British Library and university consortia.

Category:Pharmacology